Key facts
- This page summarizes Laurie Keating's Form 4 filing for ALNYLAM PHARMACEUTICALS, INC. (ALNY).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2021, 16:09.
Laurie Keating - 05 Aug 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)
- Reporting relationship
- EVP, Chief Legal Officer
- Issuer ticker
- ALNY
- Reported as of
- 05 Aug 2021
- Net transaction value
- -$1,000,000
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2021, 16:09:55 UTC
- Prior SEC filing
- 04 Aug 2021
- Next SEC filing
- 19 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Laurie Keating
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Laurie Keating filed Form 4 for ALNYLAM PHARMACEUTICALS, INC. (ALNY) on 09 Aug 2021.
Change
- Previous filing in this sequence was filed on 04 Aug 2021.
- Current net transaction value: -$1,000,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALNY
transaction
Common Stock
Options Exercise
- Transaction value
- $700,570
- Shares
- +7,876
- Change %
- +153%
- Price
- $88.95
- Shares after
- 13,008
- Date
- 05 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
ALNY
transaction
Common Stock
Options Exercise
- Transaction value
- $188,930
- Shares
- +2,124
- Change %
- +16%
- Price
- $88.95
- Shares after
- 15,132
- Date
- 05 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
ALNY
transaction
Common Stock
Sale
- Transaction value
- $1,889,500
- Shares
- -10,000
- Change %
- -66%
- Price
- $188.95
- Shares after
- 5,132
- Date
- 05 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
ALNY
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 434
- Date
- 05 Aug 2021
- Ownership
- by Managed Account
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALNY
transaction
Derivative
Performance Stock Option 2015 (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,124
- Change %
- -15%
- Price
- $0.000000
- Shares after
- 11,876
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,124
- Exercise price
- $88.95
- Footnotes
- F1
ALNY
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -7,876
- Change %
- -88%
- Price
- $0.000000
- Shares after
- 1,124
- Date
- 05 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,876
- Exercise price
- $88.95
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
Footnote F2
Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
Footnote F3
The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.